Potential therapeutic targets for <i>Cryptococcus</i>
Cryptococcus is a deadly opportunistic pathogenic fungus that causes severe infections such as meningitis in immunocompromised patients. Current antifungal therapeutics face the problem of drug resistance and the limitation of high side effects, and there is an urgent need to develop new therapeutic strategies. The growth and pathogenicity of Cryptococcus depend on its complex metabolic network, and by interfering with the metabolic pathways of Cryptococcus, its virulence can be effectively reduced and the immune response of the host enhanced. This paper systematically summarizes the potential therapeutic targets of protein, sugar, lipid, and metal metabolism of Cryptococcus and their mechanisms of action, which provides theoretical support for the development of novel antifungal drugs and brings new hope to the growing problem of fungal infections.
Authors
- Jing Liu (ORCID: https://orcid.org/0000-0002-8477-6572)
- Xinying Xue (ORCID: https://orcid.org/0000-0002-7847-8034)
- Yangyu Zhou
- Hengyu Deng
- Xuelei Zang (ORCID: https://orcid.org/0000-0002-0544-1900)
- Yemei Huang
- Enqi Zhao
- Ziqi Zhao
- Xiaozhuo Dong
Institutions
- Weifang Medical University (CN)
- Capital Medical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- Medical Mycology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1093/mmy/myag015
- Primary Topic
- Fungal Infections and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00